Evidence map›Paper›PMID 33317546›Full record

ArticleJournal of translational medicine2020

Human breast milk as source of sphingolipids for newborns: comparison with infant formulas and commercial cow's milk.

Michele Dei Cas, Rita Paroni, Paola Signorelli, Alessandra Mirarchi, Laura Cerquiglini, Stefania Troiani, Samuela Cataldi, Michela Codini, Tommaso Beccari, Riccardo Ghidoni and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Milk Fat Globules: 2024 Updates.Newborn (Clarksville, Md.)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Michele Dei CasDepartment of Health Sciences, Università degli Studi di Milano, Milan, 20142, Italy.
Rita ParoniDepartment of Health Sciences, Università degli Studi di Milano, Milan, 20142, Italy.
Paola SignorelliDepartment of Health Sciences, Università degli Studi di Milano, Milan, 20142, Italy.
Alessandra MirarchiDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, 06126, Italy.
Laura CerquigliniStruttura Complessa di Neonatologia e Terapia Intensiva Neonatale- Azienda Ospedaliera Santa Maria della Misericordia, Perugia, 06126, Italy.
Stefania TroianiStruttura Complessa di Neonatologia e Terapia Intensiva Neonatale- Azienda Ospedaliera Santa Maria della Misericordia, Perugia, 06126, Italy.
Samuela CataldiDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, 06126, Italy.
Michela CodiniDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, 06126, Italy.
Tommaso BeccariDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, 06126, Italy.
Riccardo GhidoniAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, Università degli Studi di Milano, Milan, 20142, Italy.
Elisabetta AlbiDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, 06126, Italy. elisabetta.albi@unipg.it.ORCID 0000-0002-5745-5343
University of Perugia · ITUniversity of Milan · ITAzienda Ospedaliera di Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the past two decades, sphingolipids have become increasingly appreciated as bioactive molecules playing important roles in a wide array of pathophysiology mechanisms. Despite advances in the field, sphingolipids as nutrients remain little explored. Today the research is starting to move towards the study of the sphingomyelin content in human breast milk, recommended for feeding infants.

methodsIn the present study, we performed a lipidomic analysis in human breast milk in relation with maternal diet during pregnancy, in infant formulas, and in commercial whole and semi-skimmed milks for adults. Mediterranean, carnivorous and vegetarian diets were considered.

resultsThe results showed that total sphingomyelin, ceramide and dihydroceramide species are independent on the diet. Interestingly, the milk sphingolipid composition is species-specific. In fact, infant formulas and commercial milks for adults have a lower level of total sphingomyelin and ceramide content than human breast milk with very different composition of each sphingolipid species.

conclusionsWe conclude that human breast milk is a better source of sphingolipids than infant formulas for baby nutrition with potential implications for the brain development and cognitive functions.

Indexed as

Infant FormulaMilkAdultAnimalsCattleFemaleHumansInfantInfant, NewbornMilk, HumanPregnancySphingolipidsSphingolipidsCeramideCow’s milkHuman breast milkInfant formulasLipidomicSphingomyelin

Identifiers

PMID33317546
PMCPMC7734711
OpenAlexW3111957589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.